Trevor, Anthony J.; Katzung, Bertram G. (2003). 《Pharmacology》. New York: Lange Medical Books/McGraw-Hill, Medical Publishing Division. 43쪽. ISBN978-0-07-139930-2.
Brugada P (July 2000). “Magnesium: an antiarrhythmic drug, but only against very specific arrhythmias”. 《Eur. Heart J.》 21 (14): 1116. doi:10.1053/euhj.2000.2142. PMID10924290.
Hoshino K, Ogawa K, Hishitani T, Isobe T, Eto Y (October 2004). “Optimal administration dosage of magnesium sulfate for torsades de pointes in children with long QT syndrome”. 《J Am Coll Nutr》 23 (5): 497S–500S. doi:10.1080/07315724.2004.10719388. PMID15466950. S2CID30146333.
Hoshino K, Ogawa K, Hishitani T, Isobe T, Etoh Y (April 2006). “Successful uses of magnesium sulfate for torsades de pointes in children with long QT syndrome”. 《Pediatr Int》 48 (2): 112–17. doi:10.1111/j.1442-200X.2006.02177.x. PMID16635167. S2CID24904388.
Damato, Anthony N. (1969년 7월 1일). “Diphenylhydantoin: Pharmacological and clinical use”. 《Progress in Cardiovascular Diseases》 12 (1): 1–15. doi:10.1016/0033-0620(69)90032-2. PMID5807584.
Brugada P (July 2000). “Magnesium: an antiarrhythmic drug, but only against very specific arrhythmias”. 《Eur. Heart J.》 21 (14): 1116. doi:10.1053/euhj.2000.2142. PMID10924290.
Hoshino K, Ogawa K, Hishitani T, Isobe T, Eto Y (October 2004). “Optimal administration dosage of magnesium sulfate for torsades de pointes in children with long QT syndrome”. 《J Am Coll Nutr》 23 (5): 497S–500S. doi:10.1080/07315724.2004.10719388. PMID15466950. S2CID30146333.
Hoshino K, Ogawa K, Hishitani T, Isobe T, Etoh Y (April 2006). “Successful uses of magnesium sulfate for torsades de pointes in children with long QT syndrome”. 《Pediatr Int》 48 (2): 112–17. doi:10.1111/j.1442-200X.2006.02177.x. PMID16635167. S2CID24904388.
Charlier, R; Deltour, G; Baudine, A; Chaillet, F (November 1968). “Pharmacology of amiodarone, and anti-anginal drug with a new biological profile.”. 《Arzneimittel-Forschung》 18 (11): 1408–17. PMID5755904.
Damato, Anthony N. (1969년 7월 1일). “Diphenylhydantoin: Pharmacological and clinical use”. 《Progress in Cardiovascular Diseases》 12 (1): 1–15. doi:10.1016/0033-0620(69)90032-2. PMID5807584.
“The 'Sicilian Gambit'. A new approach to the classification of antiarrhythmic drugs based on their actions on arrhythmogenic mechanisms. The Task Force of the Working Group on Arrhythmias of the European Society of Cardiology”. 《Eur. Heart J.》 12 (10): 1112–31. October 1991. PMID1723682.
Hoshino K, Ogawa K, Hishitani T, Isobe T, Eto Y (October 2004). “Optimal administration dosage of magnesium sulfate for torsades de pointes in children with long QT syndrome”. 《J Am Coll Nutr》 23 (5): 497S–500S. doi:10.1080/07315724.2004.10719388. PMID15466950. S2CID30146333.
Hoshino K, Ogawa K, Hishitani T, Isobe T, Etoh Y (April 2006). “Successful uses of magnesium sulfate for torsades de pointes in children with long QT syndrome”. 《Pediatr Int》 48 (2): 112–17. doi:10.1111/j.1442-200X.2006.02177.x. PMID16635167. S2CID24904388.